603707.SS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (16 Apr 2024 @ 03:00):

Stats
Today's Volume	7.91M
Average Volume	11.97M
Market Cap	20.59B
EPS	CNY0.131 ( 2023-10-27 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	20.24
ATR14	CNY0.0260 (0.20%)

Volume Correlation

Long: -0.23 (neutral)

Short: 0.10 (neutral)

Signal:(25.735) Neutral

Nanjing King-Friend Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Nanjing King-Friend Correlation - Currency/Commodity

-0.19
( neutral )

-0.16
( neutral )

0.00
( neutral )

-0.31
( neutral )

-0.21
( neutral )

-0.06
( neutral )

Nanjing King-Friend Financials

Annual	2022
Revenue:	CNY3.71B
Gross Profit:	CNY1.94B (52.38 %)
EPS:	CNY0.680

Q3	2023
Revenue:	CNY838.19M
Gross Profit:	CNY405.56M (48.39 %)
EPS:	CNY0.130

Q2	2023
Revenue:	CNY996.25M
Gross Profit:	CNY483.99M (48.58 %)
EPS:	CNY0.180

Q1	2023
Revenue:	CNY1.31B
Gross Profit:	CNY662.50M (50.67 %)
EPS:	CNY0.210

Financial Reports:

No articles found.

Nanjing King-Friend

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd manufactures and sells heparin sodium and low molecular weight heparin products for pharmaceutical companies in the People's Republic of China. It offers enoxaparin sodium, dalteparin sodium, and naqu heparin calcium injections. The company also exports its products primarily to the European and American countries. The company was founded in 2000 and is based in Nanjing, the People's Republic of China.